Literature DB >> 12359219

Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase.

Norio Takizawa1, Yasuhiko Koga, Mitsuo Ikebe.   

Abstract

CPI17 and myosin binding subunit of type 1 protein phosphatase (MBS) are the regulators of myosin light chain phosphatase (MLCP). The function of both regulators is controlled by phosphorylation. The phosphorylation of CPI17 at Thr38 significantly enhances the inhibitory activity of CPI17 and the phosphorylation at Thr641 of MBS decreases the MLCP activity. Here, we found that p21-activated protein kinase (PAK) phosphorylates both CPI17 at Thr38 and MBS at Thr641. For CPI17, PAK specifically phosphorylated at Thr38, since the mutation of Thr38 to Ala completely abolished the phosphorylation. On the other hand, PAK phosphorylated Thr641 but not Thr799 of MBS, the site phosphorylated by Rho kinase. Because PAK phosphorylates MBS more than 1 mol/mol, it is anticipated that PAK also phosphorylates other sites in addition to Thr641. CPI17 phosphorylation induced by PAK significantly enhanced the inhibitory activity of CPI17. On the other hand, the phosphorylation of MBS by PAK also decreased the MLCP activity. These results raise the possibility that the PAK pathway plays a role in MLCP regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359219     DOI: 10.1016/s0006-291x(02)02302-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

2.  Localization of myosin phosphatase target subunit and its mutants.

Authors:  Yue Wu; Andrea Murányi; Ferenc Erdodi; David J Hartshorne
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

3.  The small GTPase Rac1 is required for smooth muscle contraction.

Authors:  Awahan Rahman; Benjamin Davis; Cecilia Lövdahl; Veena T Hanumaiah; Robert Feil; Cord Brakebusch; Anders Arner
Journal:  J Physiol       Date:  2013-12-02       Impact factor: 5.182

4.  Transcriptional regulatory events initiated by Ascl1 and Neurog2 during neuronal differentiation of P19 embryonic carcinoma cells.

Authors:  Holly S Huang; Tanya M Redmond; Ginger M Kubish; Shweta Gupta; Robert C Thompson; David L Turner; Michael D Uhler
Journal:  J Mol Neurosci       Date:  2014-09-06       Impact factor: 3.444

Review 5.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.

Authors:  Qing-Rong Liu; Ping-Wu Zhang; Zhicheng Lin; Qi-Fu Li; Amina S Woods; Juan Troncoso; George R Uhl
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

7.  Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Authors:  Alexander Khromov; Nandini Choudhury; Andra S Stevenson; Avril V Somlyo; Masumi Eto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

8.  A signal transduction pathway model prototype II: Application to Ca2+-calmodulin signaling and myosin light chain phosphorylation.

Authors:  Thomas J Lukas
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

9.  A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase.

Authors:  Yasuhiko Koga; Mitsuo Ikebe
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

Review 10.  Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors.

Authors:  Masumi Eto
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.